J. Petersein et al., Focal liver lesions: Evaluation of the efficacy of gadobenate dimeglumine in MR imaging - A multicenter phase III clinical study, RADIOLOGY, 215(3), 2000, pp. 727-736
Citations number
34
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
PURPOSE: To evaluate gadobenate dimeglumine (Cd-BOPTA) for dynamic and dela
yed magnetic resonance (MR) imaging of focal liver lesions.
MATERIALS AND METHODS: In 126 of 214 patients, MR imaging was performed bef
ore Cd-BOPTA administration, immediately after bolus administration of a 0.
05-mmol/kg dose of Cd-BOPTA, and 60-120 minutes after an additional intrave
nously infused 0.05-mmol/kg dose. In 88 patients, imaging was performed bef
ore and 60-120 minutes after a single, intravenously infused 0.1-mmol/kg do
se. T1- and T2-weighted spin-echo and T1-weighted gradient-echo images were
acquired. On-site and blinded off-site reviewers prospectively evaluated a
ll images. Intraoperative ultrasonography, computed tomography (CT) during
arterial portography, and/or CT with iodized oil served as the reference me
thods in 110 patients.
RESULTS: Significantly more lesions were detected on combined pre- and post
contrast images compared with on precontrast images alone (P < .01). All re
viewers reported a decreased mean size of the smallest detected lesion and
improved lesion conspicuity on postcontrast images. All on-cite reviewers a
nd two off-site reviewers reported increased overall diagnostic confidence
(P < .01). Additional lesion characterization information was provided on u
p to 109 (59%) of 184 delayed images and for up to 50 (42%) of 118 patients
in whom dynamic images were assessed. Cd-BOPTA would have helped change th
e diagnosis in 99 (47%) of 209 cases and affected patient treatment in 408
(23%) of 209 cases.
CONCLUSION: Cd-BOPTA increases liver lesion conspicuity and detectability a
nd aids in the characterization of lesions.